Cargando…

Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study

BACKGROUND: Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare neuroendocrine tumors characterized by hemodynamic instability, caused by the paroxysmal release of catecholamines. Patients may develop cardiovascular complications in the perioperative phase due to the massive release of catechol...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Filpo, Giuseppina, Parenti, Gabriele, Sparano, Clotilde, Rastrelli, Giulia, Rapizzi, Elena, Martinelli, Serena, Amore, Francesca, Badii, Benedetta, Paolo, Prosperi, Ercolino, Tonino, Mannelli, Massimo, Maggi, Mario, Canu, Letizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294368/ https://www.ncbi.nlm.nih.gov/pubmed/37370080 http://dx.doi.org/10.1186/s12957-023-03072-z

Ejemplares similares

Correction: Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
por: De Filpo, Giuseppina, et al.
Publicado: (2023)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
por: Parenti, Gabriele, et al.
Publicado: (2012)

Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience
por: De Filpo, G., et al.
Publicado: (2021)

Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia
por: Provenzano, Aldesia, et al.
Publicado: (2022)

Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts
por: Martinelli, Serena, et al.
Publicado: (2022)

Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma
por: De Filpo, Giuseppina, et al.
Publicado: (2020)

Pheochromocytoma/paraganglioma preclinical models: which to use and why?
por: Martinelli, Serena, et al.
Publicado: (2020)

Sunitinib in the therapy of malignant paragangliomas: report on the efficacy in a SDHB mutation carrier and review of the literature
por: Canu, Letizia, et al.
Publicado: (2016)

A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy
por: Canu, Letizia, et al.
Publicado: (2021)

Genetic-Clinical Profile of Subjects with Apparently Sporadic Extra-Adrenal Paragangliomas
por: Ramundo, Valeria, et al.
Publicado: (2012)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021)

Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
por: Cantini, Giulia, et al.
Publicado: (2020)

SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation
por: De Filpo, Giuseppina, et al.
Publicado: (2020)

Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
por: Richter, Susan, et al.
Publicado: (2018)

Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma
por: Ma, Lulu, et al.
Publicado: (2020)

Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients
por: Kim, Jung Hee, et al.
Publicado: (2021)

Preoperative blood pressure targets and effect on hemodynamics in pheochromocytoma and paraganglioma
por: Ugleholdt, Randi, et al.
Publicado: (2022)

Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome
por: Murro, Vittoria, et al.
Publicado: (2021)

Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression
por: Cantini, Giulia, et al.
Publicado: (2021)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
por: Sarkadi, Balazs, et al.
Publicado: (2020)

Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
por: Kim, Jung Hee, et al.
Publicado: (2022)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
por: Calsina, Bruna, et al.
Publicado: (2023)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022)

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
por: Gieldon, Laura, et al.
Publicado: (2019)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Dopamine-Secreting Pheochromocytoma and Paraganglioma
por: Miyamoto, Shotaro, et al.
Publicado: (2021)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
por: Ku, Eu Jeong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c563fuckaaq25ck7ptu63au504